KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Change in Acquisitions & Divestments (2020 - 2023)

Astrana Health's Change in Acquisitions & Divestments history spans 4 years, with the latest figure at $491000.0 for Q4 2023.

  • For Q4 2023, Change in Acquisitions & Divestments fell 98.05% year-over-year to $491000.0; the TTM value through Dec 2024 reached $25.7 million, changed 0.16%, while the annual FY2024 figure was $124000.0, 74.75% down from the prior year.
  • Change in Acquisitions & Divestments for Q4 2023 was $491000.0 at Astrana Health, down from $25.2 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $66.5 million in Q4 2021 and bottomed at -$42000.0 in Q3 2022.
  • The 4-year median for Change in Acquisitions & Divestments is $6.5 million (2022), against an average of $21.5 million.
  • The largest annual shift saw Change in Acquisitions & Divestments skyrocketed 31.37% in 2021 before it crashed 98.05% in 2023.
  • A 4-year view of Change in Acquisitions & Divestments shows it stood at $50.6 million in 2020, then soared by 31.37% to $66.5 million in 2021, then plummeted by 62.06% to $25.2 million in 2022, then plummeted by 98.05% to $491000.0 in 2023.
  • Per Business Quant, the three most recent readings for ASTH's Change in Acquisitions & Divestments are $491000.0 (Q4 2023), $25.2 million (Q4 2022), and -$42000.0 (Q3 2022).